Anatomic, Physiologic and Transcriptomic Mechanisms of Neuropathic Pain in Human DRG

人类背根神经节神经病理性疼痛的解剖学、生理学和转录组学机制

基本信息

项目摘要

We have launched a collaborative effort between MD Anderson Cancer Center and University of Texas at Dallas that uses dorsal root ganglion (DRG) removed from pain phenotyped patients during neurological surgery. DRGs are taken from thoracic levels during a spine stabilization surgery and then cut in thirds. One third is saved for immunohistochemistry (IHC) or in situ hybridization (ISH), one third goes for culturing and electrophysiology, and one third is used for RNA sequencing. We have developed an extensive dataset with patient pain phenotype information, DRG neuron electrophysiological characterization and RNA sequencing. In many cases we have pairs of DRGs from the same patient where the patient had pain in one dermatome and not in another, allowing for precise case-control analysis. Our electrophysiology results clearly demonstrate that chronic pain is associated with spontaneous activity (SA) in DRG nociceptors. This is the first time that this has been demonstrated. Our RNA sequencing results identify transcriptional changes associated with chronic pain and SA in the DRG that show indications of sexual dimorphism. In males we find clear signs of immune infiltration and neuro-immune interactions as well as an increase in expression for some members of the FOS/JUN transcription factor family. In females we see an upregulation of some G-protein coupled receptors (GPCRs) and other signs of intrinsic changes in neuronal excitability. These findings give unique insights into drivers of chronic pain in the DRG in a diverse cohort of patients with important implications for chronic pain therapeutic development, including the potential need for sex-specific treatment. Our overarching hypothesis is that SA in human DRG neurons, which is a critical factor for pain generation in patients, is driven by fundamentally different mechanisms in male and female patients. We will test this hypothesis using human DRG samples and a combination of electrophysiology (Aim 1) and RNA-seq (Aim 2). In Aim 3 IHC and ISH along with pharmacological interventions guided by preliminary findings and data generated during this project will be used to define new potential therapeutic avenues. In sum, the experiments in this project will give fundamental new insight into mechanisms of chronic pain that will enable therapeutic and biomarker discovery with the opportunity for an almost immediate impact on clinical care.
我们已经启动了MD安德森癌症中心和密歇根大学之间的合作努力, 德克萨斯州达拉斯的一家研究机构,该机构使用从疼痛表型患者身上取出的背根神经节(DRG 在神经外科手术中。在脊柱稳定期间,从胸椎水平采集DRG 手术,然后切成三分之一。三分之一保存用于免疫组织化学(IHC)或原位 杂交(ISH),三分之一用于培养和电生理学,三分之一用于 RNA测序。我们已经开发了一个广泛的患者疼痛表型数据集 信息,DRG神经元电生理表征和RNA测序。在许多 在病例中,我们有来自同一患者的成对DRG,其中一个患者疼痛 而不是在另一个,允许精确的病例对照分析。我们的电生理学 结果清楚地表明,慢性疼痛与自发活动(SA)有关, 背根神经节伤害感受器。这是第一次证明这一点。我们的RNA测序 结果确定了与DRG中慢性疼痛和SA相关的转录变化, 显示出两性异形的迹象在男性中,我们发现了免疫渗透的明显迹象, 神经免疫相互作用以及一些成员的表达增加, FOS/JUN转录因子家族。在女性中,我们看到一些G蛋白的上调 偶联受体(GPCR)和神经元兴奋性内在变化的其他迹象。这些 研究结果为DRG中慢性疼痛的驱动因素提供了独特的见解, 对慢性疼痛治疗发展具有重要意义的患者,包括 可能需要性别特异性治疗。我们的总体假设是,人DRG中的SA 神经元是患者疼痛产生的关键因素, 男性和女性患者的不同机制。我们将使用人类来测试这一假设。 DRG样品以及电生理学(目标1)和RNA-seq(目标2)的组合。目标3 IHC和ISH沿着以初步发现和数据为指导的药物干预 在这个项目中产生的将被用来定义新的潜在的治疗途径。总的来说, 该项目的实验将为慢性炎症的机制提供基本的新见解。 疼痛,这将使治疗和生物标志物的发现, 对临床护理的直接影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Patrick M Dougherty其他文献

Patrick M Dougherty的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Patrick M Dougherty', 18)}}的其他基金

Targeting TLR4-lipid rafts to prevent postoperative pain
靶向 TLR4 脂筏预防术后疼痛
  • 批准号:
    10701528
  • 财政年份:
    2023
  • 资助金额:
    $ 65.27万
  • 项目类别:
Anatomic, Physiologic and Transcriptomic Mechanisms of Neuropathic Pain in Human DRG
人类背根神经节神经病理性疼痛的解剖学、生理学和转录组学机制
  • 批准号:
    10268154
  • 财政年份:
    2020
  • 资助金额:
    $ 65.27万
  • 项目类别:
Anatomic, Physiologic and Transcriptomic Mechanisms of Neuropathic Pain in Human DRG
人类背根神经节神经病理性疼痛的解剖学、生理学和转录组学机制
  • 批准号:
    10379957
  • 财政年份:
    2020
  • 资助金额:
    $ 65.27万
  • 项目类别:
The role of ENF loss, TLR4 and spinal plasticity in paclitaxel CIPN
ENF 缺失、TLR4 和脊柱可塑性在紫杉醇 CIPN 中的作用
  • 批准号:
    9271164
  • 财政年份:
    2016
  • 资助金额:
    $ 65.27万
  • 项目类别:
Mechanisms of Chemotherapy-Induced Peripheral Pain
化疗引起的周围疼痛的机制
  • 批准号:
    8475675
  • 财政年份:
    2007
  • 资助金额:
    $ 65.27万
  • 项目类别:
Mechanisms of Chemotherapy-Induced Peripheral Pain
化疗引起的周围疼痛的机制
  • 批准号:
    8640982
  • 财政年份:
    2007
  • 资助金额:
    $ 65.27万
  • 项目类别:
Mechanisms of Cancer Therapy-Induced Pain
癌症治疗引起的疼痛的机制
  • 批准号:
    7213577
  • 财政年份:
    2007
  • 资助金额:
    $ 65.27万
  • 项目类别:
Mechanisms of Cancer Therapy-Induced Pain
癌症治疗引起的疼痛的机制
  • 批准号:
    7354748
  • 财政年份:
    2007
  • 资助金额:
    $ 65.27万
  • 项目类别:
Mechanisms of Chemotherapy-Induced Peripheral Pain
化疗引起的周围疼痛的机制
  • 批准号:
    8401100
  • 财政年份:
    2007
  • 资助金额:
    $ 65.27万
  • 项目类别:
Mechanisms of Cancer Therapy-Induced Pain
癌症治疗引起的疼痛的机制
  • 批准号:
    7561642
  • 财政年份:
    2007
  • 资助金额:
    $ 65.27万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 65.27万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.27万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 65.27万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.27万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 65.27万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 65.27万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.27万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 65.27万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 65.27万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.27万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了